je.st
news
Merck, on Behalf of Its Wholly Owned Subsidiary Cubist Pharmaceuticals, Announces Results of Tender Offer for Cubists 2.50% Convertible Senior Notes Due 2017, 1.125% Convertible Senior Notes Due 2018 and 1.875% Convertible Senior Notes Due 2020
2015-02-23 23:03:00| Merck.com - Corporate News
Dateline City: KENILWORTH, N.J. KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, on behalf of its wholly owned subsidiary Cubist Pharmaceuticals, Inc., today announced the results of its tender offer (the Convertible Notes Tender Offer) pursuant to which each holder of Cubists 2.50% Convertible Senior Notes due 2017 (the 2017 Convertible Notes), 1.125% Convertible Senior Notes due 2018 (the 2018 Convertible Notes) and 1.875% Convertible Senior Notes due 2020 (the 2020 Convertible Notes and together with th Language: English Contact: MerckMedia:Lainie Keller, (908) 236-5036Steve Cragle, (908) 740-1801orInvestor:Joe Romanelli, (908) 740-1986Justin Holko, (908) 740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: results
due
offer
notes
Category:Biotechnology and Pharmaceuticals